Login to Your Account



Ono teams with Numab in $262M multispecific antibody pact in I-O

By Cormac Sheridan
Staff Writer

Tuesday, March 28, 2017

DUBLIN – Numab Therapeutics AG could earn up to CHF258 million in up-front and milestone payments from a research and option agreement with Ono Pharmaceutical Co. Ltd.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription